Interventional procedure overview of aortic valve reconstruction using glutaraldehyde-treated autologous pericardium for aortic valve disease
Closed for comments This consultation ended on at Request commenting lead permission
Methods
NICE identified studies and reviews relevant to aortic valve reconstruction with glutaraldehyde-treated autologous pericardium from the medical literature. The following databases were searched between the date they started to 19/10/2022: MEDLINE, PREMEDLINE, EMBASE, Cochrane Library and other databases. Trial registries and the internet were also searched (see the literature search strategy). Relevant published studies identified during consultation or resolution that are published after this date may also be considered for inclusion.
The following inclusion criteria were applied to the abstracts identified by the literature search.
Publication type: clinical studies were included with emphasis on identifying good quality studies. Abstracts were excluded if they did not report clinical outcomes. Reviews, editorials, and laboratory or animal studies, were also excluded and so were conference abstracts, because of the difficulty of appraising study methodology, unless they reported specific adverse events that not available in the published literature.
Patients with aortic valve diseases.
Intervention or test: aortic valve reconstruction with glutaraldehyde-treated autologous pericardium.
Outcome: articles were retrieved if the abstract contained information relevant to the safety, efficacy, or both.
If selection criteria could not be determined from the abstracts the full paper was retrieved.
Potentially relevant studies not included in the main evidence summary are listed in the section on other relevant studies.
Find out more about how NICE selects the evidence for the committee.
Databases | Date searched | Version/files |
|---|---|---|
MEDLINE (Ovid) | 19/10/2022 | 1946 to October 18, 2022 |
MEDLINE In-Process (Ovid) | 19/10/2022 | 1946 to October 18, 2022 |
MEDLINE Epubs ahead of print (Ovid) | 19/10/2022 | October 18, 2022 |
EMBASE (Ovid) | 19/10/2022 | 1974 to 2022 October 17 |
EMBASE Conference (Ovid) | 19/10/2022 | 1974 to 2022 October 17 |
Cochrane Database of Systematic Reviews – CDSR (Cochrane Library) | 19/10/2022 | Issue 10 of 12, October 2022 |
Cochrane Central Database of Controlled Trials – CENTRAL (Cochrane Library) | 19/10/2022 | Issue 10 of 12, October 2022 |
International HTA database (INAHTA) | 19/10/2022 | - |
Trial sources searched
Clinicaltrials.gov
ISRCTN
WHO International Clinical Trials Registry
Websites searched
National Institute for Health and Care Excellence (NICE)
NHS England
Food and Drug Administration (FDA) - MAUDE database
Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP – S)
Australia and New Zealand Horizon Scanning Network (ANZHSN)
General internet search
The following search strategy was used to identify papers in MEDLINE. A similar strategy was used to identify papers in other databases.
The MEDLINE search strategy was translated for use in the other sources.
1 Aortic Valve/ 38262
2 Heart Valve Diseases/ 25387
3 exp Aortic Valve Disease/ 62415
4 (aortic* adj4 (insufficient* or narrow* or stenos* or incompetenc* or regurgitat* or disease* or aneurysm)).tw. 62048
5 Endocarditis, Bacterial/ 20359
6 ((infect* or bacterial*) adj4 endocarditis).tw. 18473
7 or/1-6 153840
8 Heart Valve Prosthesis/ 39516
9 Heart Valve Prosthesis Implantation/ 26536
10 (valve adj4 (neocuspidi?ation or neo-cuspidi?ation or reconstruct* or repair* or replace*)).tw. 43778
11 or/8-10 73739
12 7 and 11 44074
13 Pericardium/ 16775
14 (pericardium or pericardial or epicardium).tw. 34383
15 13 or 14 41386
16 12 and 15 1867
17 Glutaral/ 7236
18 glutaraldehyde*.tw. 16055
19 17 or 18 18317
20 16 and 19 192
21 ((Ozaki* adj4 (sizer or procedure* or technique*)) or AVNEO or (aortic adj4 valve adj4 neocuspidization) or xAVNEO or (xenologous adj4 AVNEO)).tw. 86
22 Ozaki*.tw. 176
23 22 and 7 62
24 20 or 21 or 23 261
25 Animals/ not Humans/ 5023025
26 24 not 25 220
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions